These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 36983569)

  • 1. Clinical Features and Outcomes of Japanese Patients with Giant Cell Arteritis: A Comparison with Takayasu Arteritis.
    Yoshida S; Suzuki E; Sumichika Y; Saito K; Matsumoto H; Temmoku J; Fujita Y; Matsuoka N; Asano T; Sato S; Watanabe H; Migita K
    J Pers Med; 2023 Feb; 13(3):. PubMed ID: 36983569
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does glucocorticosteroid-resistant large-vessel vasculitis (giant cell arteritis and Takayasu arteritis) exist and how can remission be achieved? A critical review of the literature.
    Kötter I; Henes JC; Wagner AD; Loock J; Gross WL
    Clin Exp Rheumatol; 2012; 30(1 Suppl 70):S114-29. PubMed ID: 22640655
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HLA-B52 allele in giant cell arteritis may indicate diffuse large-vessel vasculitis formation: a retrospective study.
    Kushimoto K; Ayano M; Nishimura K; Nakano M; Kimoto Y; Mitoma H; Ono N; Arinobu Y; Akashi K; Horiuchi T; Niiro H
    Arthritis Res Ther; 2021 Sep; 23(1):238. PubMed ID: 34517892
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognosis of large vessel involvement in large vessel vasculitis.
    Vautier M; Dupont A; de Boysson H; Comarmond C; Mirault T; Mekinian A; Lambert M; Ferfar Y; Aouba A; Cacoub P; Resche-Rigon M; Saadoun D
    J Autoimmun; 2020 Mar; 108():102419. PubMed ID: 32035747
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical profile and outcome of large-vessel giant cell arteritis in Japanese patients: A single-centre retrospective cohort study.
    Yamaguchi E; Kadoba K; Watanabe R; Iwasaki T; Kitagori K; Akizuki S; Murakami K; Nakashima R; Hashimoto M; Tanaka M; Morinobu A; Yoshifuji H
    Mod Rheumatol; 2023 Jan; 33(1):175-181. PubMed ID: 35141755
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical features and radiological findings in large vessel vasculitis: are Takayasu arteritis and giant cell arteritis 2 different diseases or a single entity?
    Furuta S; Cousins C; Chaudhry A; Jayne D
    J Rheumatol; 2015 Feb; 42(2):300-8. PubMed ID: 25399386
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sustained remission after long-term biological therapy in patients with large vessel vasculitis: an analysis of ten cases.
    Vinicki JP; García-Vicuña R; Arredondo M; López-Bote JP; García-Vadillo JA; Castañeda S; Álvaro-Gracia JM
    Reumatol Clin; 2017; 13(4):210-213. PubMed ID: 27499427
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Takayasu arteritis and large-vessel giant cell arteritis in Italian population. Comprehensive analysis from a single institutional cohort of 184 cases.
    Boiardi L; Galli E; Macchioni P; Muratore F; Klinowski G; Hunder GG; Casali M; Besutti G; Spaggiari L; Versari A; Croci S; Mancuso P; Rossi PG; Marvisi C; Salvarani C
    Semin Arthritis Rheum; 2023 Apr; 59():152173. PubMed ID: 36780709
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence and prevalence of large vessel vasculitis (giant cell arteritis and Takayasu arteritis) in northern Italy: A population-based study.
    Muratore F; Boiardi L; Mancuso P; Restuccia G; Galli E; Marvisi C; Macchioni P; Rossi PG; Salvarani C
    Semin Arthritis Rheum; 2021 Aug; 51(4):786-792. PubMed ID: 34148007
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Temporal Arteritis Revealing Antineutrophil Cytoplasmic Antibody-Associated Vasculitides: A Case-Control Study.
    Delaval L; Samson M; Schein F; Agard C; Tréfond L; Deroux A; Dupuy H; Garrouste C; Godmer P; Landron C; Maurier F; le Guenno G; Rieu V; Desblache J; Durel CA; Jousselin-Mahr L; Kassem H; Pugnet G; Queyrel V; Swiader L; Blockmans D; Sacré K; Lazaro E; Mouthon L; Aumaître O; Cathébras P; Guillevin L; Terrier B;
    Arthritis Rheumatol; 2021 Feb; 73(2):286-294. PubMed ID: 32951354
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retrospective analysis of 95 patients with large vessel vasculitis: a single center experience.
    Yoshida M; Watanabe R; Ishii T; Machiyama T; Akita K; Fujita Y; Shirota Y; Sugimura K; Fujii H; Shimokawa H; Harigae H
    Int J Rheum Dis; 2016 Jan; 19(1):87-94. PubMed ID: 26443306
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patterns of extracranial involvement in newly diagnosed giant cell arteritis assessed by physical examination, colour coded duplex sonography and FDG-PET.
    Förster S; Tato F; Weiss M; Czihal M; Rominger A; Bartenstein P; Hacker M; Hoffmann U
    Vasa; 2011 May; 40(3):219-27. PubMed ID: 21638250
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary Large Vessel Vasculitis: Takayasu Arteritis and Giant Cell Arteritis.
    Romero-Sanchez G; Dabiri M; Mossa-Basha M
    Neuroimaging Clin N Am; 2024 Feb; 34(1):53-65. PubMed ID: 37951705
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical phenotype and complications of large vessel giant cell arteritis: A systematic review and meta-analysis.
    Lyne SA; Ruediger C; Lester S; Kaur G; Stamp L; Shanahan EM; Hill CL
    Joint Bone Spine; 2023 Jul; 90(4):105558. PubMed ID: 36858169
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tocilizumab for the treatment of large-vessel vasculitis (giant cell arteritis, Takayasu arteritis) and polymyalgia rheumatica.
    Unizony S; Arias-Urdaneta L; Miloslavsky E; Arvikar S; Khosroshahi A; Keroack B; Stone JR; Stone JH
    Arthritis Care Res (Hoboken); 2012 Nov; 64(11):1720-9. PubMed ID: 22674883
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Familial risks between giant cell arteritis and Takayasu arteritis and other autoimmune diseases in the population of Sweden.
    Thomsen H; Li X; Sundquist K; Sundquist J; Försti A; Hemminki K
    Sci Rep; 2020 Nov; 10(1):20887. PubMed ID: 33257751
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of Giant Cell Arteritis and Takayasu Arteritis-Current and Future.
    Hellmich B; Águeda AF; Monti S; Luqmani R
    Curr Rheumatol Rep; 2020 Oct; 22(12):84. PubMed ID: 33044642
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Takayasu arteritis and giant cell arteritis: a spectrum within the same disease?
    Maksimowicz-McKinnon K; Clark TM; Hoffman GS
    Medicine (Baltimore); 2009 Jul; 88(4):221-226. PubMed ID: 19593227
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insufficient Use of Corticosteroids without Immunosuppressants Results in Higher Relapse Rates in Takayasu Arteritis.
    Mutoh T; Shirai T; Fujii H; Ishii T; Harigae H
    J Rheumatol; 2020 Feb; 47(2):255-263. PubMed ID: 31092708
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Presenting features and outcomes of cranial-limited and large-vessel giant cell arteritis: a retrospective cohort study.
    Tomelleri A; Campochiaro C; Sartorelli S; Farina N; Baldissera E; Dagna L
    Scand J Rheumatol; 2022 Jan; 51(1):59-66. PubMed ID: 33913792
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.